PEGylation of interleukin-10 improves the pharmacokinetic profile and enhances the antifibrotic effectivity in CCl₄-induced fibrogenesis in mice.

Related Articles

PEGylation of interleukin-10 improves the pharmacokinetic profile and enhances the antifibrotic effectivity in CCl₄-induced fibrogenesis in mice.

J Control Release….

This entry was posted in J Control Release and tagged . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *